Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Accelerated Filer Status

It means, in my very humble opinion, that on November 15 2010 (when Rule 14a-11 becomes effective), PTSC will benefit from the application of the Rule being deferred for 3 years.

However, you might like to contrast my opinion with ronran's perspective:

We don't need to check your math, but your credentials may well be in need of review.

Unless the intention is to deceive, only someone with virtually zero knowledge of how statutory and/or regulatory systems work would ever place complete reliance on only one section of a provision. The issue is most certainly not solely whether a cursory review of the new reg shows that PTSC meets the mathematical criteria as a "small reporting issuer" --- rather, the issue is whether a company such as PTSC can claim such status under the new reg due to the fact that PTSC has chosen to be an "accelerated filer". For all we know, there may be a provision in the law, either stautorily or otherwise, to the effect that "accelerated filers may not claim status as small issuers" (my hypothetical paraphrase).

http://agoracom.com/ir/patriot/forums/discussion/topics/440386-milestone/messages/1438272#message

As of yet, I still await his retraction, or his learned response in support of the hypotheticals, as requested:

I would be more than happy for anyone who has looked for your suggested "exceptions" and "exceptions to the exceptions", as I have done in great depth, to categorically refute my interpretation by citing the relevant section

http://agoracom.com/ir/patriot/forums/discussion/topics/440386-milestone/messages/1438457#message

.

.

.

Be well

Share
New Message
Please login to post a reply